Three-month outcomes of treatment with faricimab or aflibercept for neovascular age-related macular degeneration: a propensity score matching study in a Japanese population.

Yosuke FukudaShoji NotomiSatomi ShioseYusuke MaeharaKohei KiyoharaKohta FujiwaraSawako HashimotoKumiko KanoKeijiro IshikawaToshio HisatomiKoh-Hei Sonoda

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2024)

The BCVA improved after three loading injections of both faricimab and aflibercept. Faricimab may provide a favorable early treatment response in reducing subretinal fluid in a Japanese cohort.

Keyphrases

age related macular degeneration
metabolic syndrome
platelet rich plasma
adipose tissue
combination therapy
insulin resistance
endothelial cells
vascular endothelial growth factor
smoking cessation